Anti-RhD antibody therapy modulates human natural killer cell function
暂无分享,去创建一个
O. Mandelboim | D. Mevorach | U. Elchalal | S. Elias | S. Kahlon | O. Zelig | Inbal Kol | R. Amore | Mariam Zeibak
[1] O. Mandelboim,et al. A BW Reporter System for Studying Receptor-Ligand Interactions. , 2019, Journal of visualized experiments : JoVE.
[2] Peter D. Crompton,et al. NK cells inhibit Plasmodium falciparum growth in red blood cells via antibody-dependent cellular cytotoxicity , 2018, eLife.
[3] F. Nimmerjahn,et al. Differential antibody glycosylation in autoimmunity: sweet biomarker or modulator of disease activity? , 2017, Nature Reviews Rheumatology.
[4] J. Ravetch,et al. Fcγ Receptor Function and the Design of Vaccination Strategies. , 2017, Immunity.
[5] G. Alter,et al. The Immunoregulatory Roles of Antibody Glycosylation. , 2017, Trends in immunology.
[6] L. Lanier,et al. NK cells and type 1 innate lymphoid cells: partners in host defense , 2016, Nature Immunology.
[7] P. Ramsland,et al. Molecular properties of human IgG subclasses and their implications for designing therapeutic monoclonal antibodies against infectious diseases. , 2015, Molecular immunology.
[8] J. Zimring,et al. IgG-Mediated Immune Suppression to Erythrocytes by Polyclonal Antibodies Can Occur in the Absence of Activating or Inhibitory Fcγ Receptors in a Full Mouse Model , 2015, The Journal of Immunology.
[9] G. Vidarsson,et al. Low anti-RhD IgG-Fc-fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newborn , 2014, British journal of haematology.
[10] M. Jordan,et al. Perforin deficiency impairs a critical immunoregulatory loop involving murine CD8(+) T cells and dendritic cells. , 2013, Blood.
[11] D. Mevorach,et al. iC3b‐opsonized apoptotic cells mediate a distinct anti‐inflammatory response and transcriptional NF‐κB‐dependent blockade , 2010, European journal of immunology.
[12] G. Garratty. The James Blundell Award Lecture 2007: Do we really understand immune red cell destruction? , 2008, Transfusion medicine.
[13] J. Prost,et al. A human anti‐D monoclonal antibody selected for enhanced FcγRIII engagement clears RhD+ autologous red cells in human volunteers as efficiently as polyclonal anti‐D antibodies , 2008, British journal of haematology.
[14] G. Denomme,et al. Antenatal administration of Rh‐immune globulin causes significant increases in the immunomodulatory cytokines transforming growth factor‐β and prostaglandin E2 , 2006, Transfusion.
[15] B. Kumpel. On the immunologic basis of Rh immune globulin (anti‐D) prophylaxis , 2006, Transfusion.
[16] Franca Ronchese,et al. Perforin-dependent elimination of dendritic cells regulates the expansion of antigen-specific CD8+ T cells in vivo. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[17] L. Zitvogel,et al. Natural-killer cells and dendritic cells: "l'union fait la force". , 2005, Blood.
[18] S. Miescher,et al. A single recombinant anti-RhD IgG prevents RhD immunization: association of RhD-positive red blood cell clearance rate with polymorphisms in the FcgammaRIIA and FcgammaIIIA genes. , 2004, Blood.
[19] A. Lazarus,et al. Mechanism of action of IVIG and anti-D in ITP. , 2003, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
[20] A. Moretta. Natural killer cells and dendritic cells: rendezvous in abused tissues , 2002, Nature Reviews Immunology.
[21] B. Kumpel. On the mechanism of tolerance to the Rh D antigen mediated by passive anti-D (Rh D prophylaxis). , 2002, Immunology letters.
[22] Giovanni Melioli,et al. Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells , 2002, The Journal of experimental medicine.
[23] G. Melioli,et al. HLA class I molecule expression is up-regulated during maturation of dendritic cells, protecting them from natural killer cell-mediated lysis. , 2001, Immunology letters.
[24] S. Miescher,et al. CHO expression of a novel human recombinant IgG1 anti-RhD antibody isolated by phage display. , 2000 .
[25] T. Omi,et al. Identification of 5' flanking sequence of RH50 gene and the core region for erythroid-specific expression. , 1998, Biochemical and biophysical research communications.
[26] R. Herberman,et al. Cytophilic immunoglobulins revisited via natural killer cells , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[27] M. Goodrick,et al. Human Rh D monoclonal antibodies (BRAD-3 and BRAD-5) cause accelerated clearance of Rh D+ red blood cells and suppression of Rh D immunization in Rh D- volunteers. , 1995, Blood.
[28] T. Whiteside,et al. Regulation of human natural cytotoxicity by IgG. IV. Association between binding of monomeric IgG to the Fc receptors on large granular lymphocytes and inhibition of natural killer (NK) cell activity. , 1993, Cellular immunology.
[29] A. Lazarus,et al. Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn. , 2009, Hematology. American Society of Hematology. Education Program.
[30] B. Kumpel,et al. Mechanism of anti-D-mediated immune suppression--a paradox awaiting resolution? , 2001, Trends in immunology.
[31] D. Roos,et al. Fc gammaRIIIa-158V/F polymorphism influences the binding of IgG by natural killer cell Fc gammaRIIIa, independently of the Fc gammaRIIIa-48L/R/H phenotype. , 1997, Blood.
[32] S. Corey,et al. Divergent phosphotyrosine signaling via Fc gamma RIIIA on human NK cells. , 1996, Cellular immunology.
[33] Wei Chen,et al. Effects of anchor structure and glycosylation of Fc gamma receptor III on ligand binding affinity , 2022 .